Pharmaceutical powerhouse GlaxoSmithKline, also known simply as GSK, reportedly has a quite successful new malaria vaccine which is touted to dramatically cut the risk of contracting the deadly disease.
Mainstream media reports that the RTS malaria vaccine has the capacity to reduce the risks of catching malaria from mosquito bite by 47 to 56 persent for severe malaria and clinical malaria, respectively.
RTS vaccine has some pretty nasty side effects, however, as reported by natural health sources and the New England Journal of Medicine, that include death!
Technically speaking, the RTS,S vaccine targets the circumsporozoite protein and is given with an adjuvant system (AS01 or AS02) which has consistently shown protection against Plasmodium falciparum malaria in children and infants in phase 2 trials.
Per the New England Journal of Medicine, the RTS vaccine had an “acceptable” side-effect profile and was immunogenic in children who were only 6 weeks of age or older.
The RTS vaccine was launched at the Bill and Melinda Gates Foundation in Seattle, which is responsible for the immunization of children worldwide, especially in third world countries, says that children should be vaccinated with RTS in three doses.
However, those three doses can result in “serious injury” or even death per Earth Times, which adds that the full array of adverse side effects may not surface for another three years!
In fact about 150 children who were used in the study while developing the RTS vaccine died from it! When the RTS vaccine was administered to children, over 15,000 of which were aged only six weeks to 17 months, the success rate was only around 35 percent.
Aside from death itself, “adverse events” reported from taking the RTS malaria vaccine included meningitis, seizures, pyrexia, myositis and anaphylaxis.
While the RTS vaccine has proven effective in as much as a third of its inoculated subjects, the known as well as unknown side effects seem to be a legitimate reason for concern.